Atlas Trials

Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion

Clinical trial NCT05836766 · UNKNOWN

Trial details

NCT number
NCT05836766
Sponsor
Beijing Tiantan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Ischemic StrokeReperfusionLarge Vessel Occlusion
Start date
2023-06-05
Primary completion
2024-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.